10 Interstitial Cystitis Clinical Trials in Detroit, ME (2026)

Q: How do I join a clinical trial in Detroit?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Detroit research site will contact you.

Recruiting Interstitial Cystitis Studies in Detroit

NCT06071377Recruiting

Achieving Understanding of the Natural History of Sickle Cell Trait (AUNT)

The main purpose of this study is to create a longitudinal cohort of those with Sickle Cell Trait (SCT) to better understand the hematologic phenotype for those that carry HbS, assess for differences ...

Detroit, ME1,000 participantsNational Alliance for Sickle Cell Centers

View Study Details

NCT05581004Recruiting

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors

This is a first-in-human study to evaluate the safety, tolerability, pharmacokinetics (PK), and anti-tumor activity of enzelkitug when administered as a single agent and in combination with atezolizum...

Detroit, ME450 participantsGenentech, Inc.

View Study Details

NCT06501040Recruiting

Increasing Knowledge and Interest in Cancer Clinical Trials

This trial investigates how well a video-based clinical trial education session works in increasing knowledge and interest in cancer clinical trials among individuals in the metropolitan Detroit regio...

Detroit, ME384 participantsHayley Thompson

View Study Details

NCT06964685Recruiting

Assessment of Support With Impella® Best Practices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

The observational study titled "Observational Assessment of Support with Impella Best Practices in Acute Myocardial Infarction Complicated by Cardiogenic Shock (OASIS-AMICS)" aims to evaluate the safe...

Detroit, ME350 participantsAbiomed Inc.

View Study Details

NCT07335497Recruiting

CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

The purpose of this study is to determine the safety and tolerability of monotherapy CR-001 and identify the maximum tolerated dose (MTD), and/or optimal biologic dose and Recommended Phase 2 Dose(s) ...

Detroit, ME290 participantsCrescent Biopharma, Inc.

View Study Details

NCT06258447Recruiting

CardiAMP Heart Failure II Trial for Patients With Ischemic Heart Failure With Reduced Ejection Fraction

Concentrated autologous bone marrow mononuclear cells (ABM MNC) contain potentially therapeutic cell factors and past studies support therapeutic benefit to patients with cardiac diseases of acute myo...

Detroit, ME250 participantsBioCardia, Inc.

View Study Details

NCT07205718Recruiting

A Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors

TAK-188 is a new medicine that targets a protein called CCR8, which is found on the surface of certain cells (Tregs) inside tumors. These cells can weaken the body's ability to fight cancer. TAK-188 m...

Detroit, ME223 participantsTakeda

View Study Details

NCT07130903Recruiting

Amplitude-Modulated Radiofrequency Electromagnetic Fields (AM RF EMF) in Combination With Fruquintinib in Refractory Metastatic Colorectal Cancer

The goal of this clinical trial is to learn if adding amplitude-modulated radiofrequency electromagnetic fields (AM RF EMF) to Fruquintinib in metastatic colorectal cancer that has not responded to ot...

Detroit, ME102 participantsBarbara Ann Karmanos Cancer Institute

View Study Details

NCT06307795Recruiting

A Study to Investigate ANS014004 in Participants With Locally Advanced or Metastatic Solid Tumors

This is a Phase 1, first-in-human, open-label, multi-center study with the aim of exploring the safety, tolerability, PK, and preliminary anti-tumor activity of ANS014004 as a single agent in particip...

Detroit, ME63 participantsAvistone Biotechnology Co., Ltd.

View Study Details

NCT06190899Recruiting

Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer

This is a Phase 1/2, open-label, randomized, dose finding and dose expansion study to evaluate the safety, preliminary efficacy, and PK of gedatolisib in combination with darolutamide in subjects with...

Detroit, ME54 participantsCelcuity Inc

View Study Details

About Interstitial Cystitis Clinical Trials in Detroit

Interstitial cystitis/bladder pain syndrome is a chronic condition causing bladder pressure, bladder pain, and sometimes pelvic pain. It primarily affects women and can significantly impact quality of life. Treatment includes dietary changes, bladder instillations, oral medications, and neuromodulation.

There are currently 10 interstitial cystitis clinical trials recruiting participants in Detroit, ME. These studies are seeking a combined 3,166 participants. Research is being sponsored by National Alliance for Sickle Cell Centers, Genentech, Inc., Hayley Thompson and 7 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Interstitial Cystitis Clinical Trials in Detroit — FAQ

Are there interstitial cystitis clinical trials in Detroit?

Yes, there are 10 interstitial cystitis clinical trials currently recruiting in Detroit, ME. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Detroit?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Detroit research site will contact you about next steps.

Are clinical trials in Detroit free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Detroit studies also compensate for your time and travel.

What interstitial cystitis treatments are being tested?

The 10 active trials in Detroit are testing new therapies including novel drugs, biologics, and treatment approaches for interstitial cystitis.

Data updated July 13, 2026 from ClinicalTrials.gov